SpaDerma Funding: How Much Did They Raise & Key Investors

How Much Did SpaDerma Raise?
Funding & Key Investors

SpaDerma, a prominent player in the medical aesthetics sector, has successfully secured significant capital to bolster its operational footprint. The firm has reached a cumulative valuation milestone with a $780K total funding amount, underscored by a recent $430K major strategic investment. This influx of capital reflects the company's robust growth trajectory and its ability to scale high-demand clinical services across its multiple Chicago-area locations.

The financial backing, structured primarily through debt financing, highlights investor confidence in the company's long-term revenue model and its dominance in the competitive skincare market. By leveraging this liquidity, SpaDerma is positioned to further solidify its market share in the rapidly evolving cosmetic dermatology landscape.

What is SpaDerma?

SpaDerma

Hospitals & Physicians Clinics

Medical Practice Management

Headquartered in Chicago, SpaDerma operates as a sophisticated medical spa network, delivering a comprehensive suite of advanced skincare, cosmetic injectables, and laser therapy solutions. With a presence in key neighborhoods such as Lincoln Park, West Loop, and the North Shore, the company has established itself as a premier destination for clinical-grade aesthetic treatments. Their service portfolio includes high-demand procedures like Hydrafacial, SkinPen, and Moxi, supported by a track record of over 3 million successful treatments. By integrating medical expertise with a retail-oriented service model, SpaDerma effectively addresses diverse consumer needs ranging from acne management and anti-aging to specialized weight loss programs.

How much funding has SpaDerma raised?

SpaDerma has raised a total of $780K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$430K

Debt (2020): $350K with participation from PPP

Debt (2021): $430K led by PPP

Key Investors in SpaDerma

PPP

Public-Private Partnership

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for SpaDerma?

With the recent infusion of capital, SpaDerma is expected to prioritize the expansion of its clinical infrastructure and the integration of next-generation aesthetic technologies. The strategic focus will likely center on enhancing operational efficiencies across its existing footprint while exploring potential new markets. As the medical spa industry continues to consolidate, SpaDerma's ability to maintain high-volume, high-quality service delivery will be critical to sustaining its competitive advantage. Future initiatives may include the adoption of proprietary skincare product lines and the scaling of its digital patient engagement platforms to drive long-term retention and brand loyalty in the premium wellness sector.

See full SpaDerma company page

See More Financial Insights